| Boswellic acid derivative, which shows anti-tumor and anti-inflammatory activities. Potent non-redox, noncompetitive 5-lipoxygenase and topoisomerase I and IIa inhibitor leading to apoptosis. Mobilizes intracellular Ca2+ and potently inhibits the MAP kinases p38 and p44/42. 10-times more potent than 3-O-Acetyl-ß-boswellic acid. Has been shown to exhibit in vivo efficacy in tumor growth and inhibition. | |
| Reference Price: | $130.00 Click to Order |
| More Information: | CAS[67416-61-9] - C32H48O5 - Cancer Research - Calcium signaling |
| Boswellic acid derivative, which shows anti-tumor and anti-inflammatory activities. Potent non-redox, noncompetitive 5-lipoxygenase and topoisomerase I and IIa inhibitor leading to apoptosis. Mobilizes intracellular Ca2+ and potently inhibits the MAP kinases p38 and p44/42. 10-times more potent than 3-O-Acetyl-ß-boswellic acid. Has been shown to exhibit in vivo efficacy in tumor growth and inhibition. | |
| Reference Price: | $130.00 Click to Order |
| More Information: | CAS[67416-61-9] - C32H48O5 - Cancer Research - Inhibitor |
| Boswellic acid derivative, which shows anti-tumor and anti-inflammatory activities. Potent non-redox, noncompetitive 5-lipoxygenase and topoisomerase I and IIa inhibitor leading to apoptosis. Mobilizes intracellular Ca2+ and potently inhibits the MAP kinases p38 and p44/42. 10-times more potent than 3-O-Acetyl-ß-boswellic acid. Has been shown to exhibit in vivo efficacy in tumor growth and inhibition. | |
| Reference Price: | $130.00 Click to Order |
| More Information: | CAS[67416-61-9] - C32H48O5 - Cancer Research - Protein kinase |
Return to Home Page
Powered By SmartWin Technology eCommerce Software